Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Drug Transport and Resistance Mechanisms, and Cervical Cancer and HPV Research.
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial
Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician’s Choice
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis
A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
Second-line lenvatinib in patients with recurrent endometrial cancer
A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients.
Safety and Efficacy Results of Retreatment With a PARP Inhibitor Monotherapy in Late-Line Recurrent Ovarian Cancer: Results From a Subset of the QUADRA Trial
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer
Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Dementia clinical trial implications of mild behavioral impairment
QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
GOG 3007, a randomized phase II (RP2) trial of everolimus and letrozole (EL) or hormonal therapy (medroxyprogesterone acetate/tamoxifen, PT) in women with advanced, persistent or recurrent endometrial carcinoma (EC): A GOG Foundation study
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
New therapies for advanced, recurrent, and metastatic endometrial cancers
Mitochondrial mutations and metabolic adaptation in pancreatic cancer
A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study
Incubating the Use of Artificial Intelligence for Conducting High-Quality Research Syntheses
Broadening the Discovery Potential of the LHC: Instrumentation, Algorithms, and Training for Physics with the ATLAS Experiment and Direct Axion Detection
Collaborative Research: How to get SMAL: Studying island dwarfism to find Shared Molecular mechanisms Across Life history traits
RAPID: Understanding and Supporting K-12 School Leaders' AI-related Decision-making
Collaborative Research: SaTC: EDU: Dual-track Role-based Learning for Cybersecurity Analysts and Engineers for Effective Defense Operation with Data Analytics
ECR Hub: Advancing the Long-Term Potential of Fundamental Research
Identifying and Reducing Gender Bias in STEM: Systematically Synthesizing the Experimental Evidence
Improving Undergraduates’ Motivation and Retention in STEM Through Classroom Interventions: A Meta-Analysis
Building for Future Discoveries: Instrumentation, Algorithms, and Training for Physics with the ATLAS Experiment
The Development of Gender Stereotypes About STEM Abilities: A Meta-Analysis
Collaborative Research: Implementing Multi-institutional Classroom-based Undergraduate Research Experiences to Study the Impact of Environmental Changes on Salamander Populations
CAREER: Boosting Signals for Hidden Supersymmetry with the ATLAS Hadronic Calorimeter
BOOST 2015 Workshop Hosted by the Enrico Fermi Institute at the University of Chicago; Chicago, IL; August 10-14, 2015.
Development of a Biology-Based Sperm Storage System
Searches for New Physics with Heavy-Flavor Rich Hadronic Final States in the Post-Higgs Era
Role of Excited Species in Plasma Enhanced Combustion
Support for the Fourth Joint Meeting of the United States Sections of the Combustion Institute; Philadelphia, PA; March 20-23, 2005
NEXT STEP: Recruiting and Supporting Associate Degree
Acquisition of a Gas Chromatograph with Mass Selective Detector
Collaborative Research: Implementation of Tabu Search for the Design of Novel Molecules using Parallel Computers
Maximum Entropy Model Learning for Classification and More General Inference Tasks: Large-scale Applications and Extensions
Collaborative Research: Vertical Divergence of Turbulent and Radiative Fluxes and Influence of Mesoscale Motions on Turbulence Intermittency